Advanced Biomed Inc.
ADVB
$4.95
$0.4910.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 210.64% | -14.90% | 97.44% | 18.62% | -85.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.59% | 0.75% | 72.08% | 2.32% | -56.99% |
| Operating Income | -41.59% | -0.75% | -72.08% | -2.32% | 56.99% |
| Income Before Tax | 1,308.32% | -45.67% | 13.32% | -31.03% | -298.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1,308.32% | -45.67% | 13.32% | -31.03% | -298.83% |
| Earnings from Discontinued Operations | 56.06% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 855.36% | -45.67% | 13.32% | -31.03% | -524.85% |
| EBIT | -41.59% | -0.75% | -72.08% | -2.32% | 56.99% |
| EBITDA | -109.45% | -13.91% | -108.48% | -3.35% | 68.68% |
| EPS Basic | 798.12% | -34.59% | 20.00% | -28.03% | -524.85% |
| Normalized Basic EPS | 45.06% | -34.94% | 19.76% | -27.88% | -298.90% |
| EPS Diluted | 798.12% | -34.59% | 20.00% | -28.03% | -524.85% |
| Normalized Diluted EPS | 45.06% | -34.94% | 19.76% | -27.88% | -298.90% |
| Average Basic Shares Outstanding | 8.20% | 8.20% | 8.17% | 2.40% | 0.00% |
| Average Diluted Shares Outstanding | 8.20% | 8.20% | 8.17% | 2.40% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |